External Source

Dr. Matulonis On Cps As A Potential Biomarker In Advanced Recurrent Ovarian Cancer

2020 0:49
Synopsis
Ursula A. Matulonis, MD, discusses the potential role of combined positive score as a biomarker in advanced recurrent ovarian ...

You Might Also Like

Dr. Matulonis on Final Data From KEYNOTE-100 in Recurrent Ovarian Cancer 1:25
Dr. Matulonis On Final Data From Keynote-100 In Recurrent Ov...
2020
Biomarkers and Molecular Testing in Ovarian Cancer 5:46
Biomarkers And Molecular Testing In Ovarian Cancer
2018
Dr. Matulonis on the Use of Immunotherapy in Recurrent Ovarian Cancer 1:17
Dr. Matulonis On The Use Of Immunotherapy In Recurrent Ovari...
2019
Ovarian Cancer — Ursula Matulonis, MD 36:24
Ovarian Cancer — Ursula Matulonis, Md
2025
KEYNOTE-100 update: pembrolizumab in patients with advanced recurrent ovarian cancer 6:40
Keynote-100 Update: Pembrolizumab In Patients With Advanced ...
2020
Copy of Dr. Matulonis on the Use of Immunotherapy in Recurrent Ovarian Cancer 0:19
Copy Of Dr. Matulonis On The Use Of Immunotherapy In Recurre...
2019
Stanford Cancer Institute Breakthroughs in Cancer: Ursula Matulonis, MD 1:04:59
Stanford Cancer Institute Breakthroughs In Cancer: Ursula Ma...
2023
Dr. Matulonis on Toxicities With Olaparib for Patients With Ovarian Cancer 1:54
Dr. Matulonis On Toxicities With Olaparib For Patients With ...
2015
Dr. Matulonis on the Current Treatment Landscape in Ovarian Cancer 1:44
Dr. Matulonis On The Current Treatment Landscape In Ovarian ...
2020
Dr. Coleman on the Utility of Biomarkers for Precision Medicine in Ovarian Cancer 1:06
Dr. Coleman On The Utility Of Biomarkers For Precision Medic...
2020
Dr. Matulonis Discusses Mirvetuximab Soravtansine Plus Pembrolizumab in Ovarian Cancer 2:16
Dr. Matulonis Discusses Mirvetuximab Soravtansine Plus Pembr...
2018
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.